Objective: Chronic Kidney Disease (CKD) has become a major health problem as a result of complicated interrelationships with diabetes mellitus, hypertension and other associated diseases. Effective management of CKD depends on patient's adherence to their dialysis plan, medications, dietary and fluid restrictions. This study aimed at systematically reviewing the adherence of adult Chronic Kidney Disease (CKD) patients with regard to their dialysis, medication, dietary and fluid restriction. PubMed, Ebsco Host, CINAHL, google scholar and grey literature were used to identify published research from 1993 -2016. Forty three (43) articles were identified regarding adherence of CKD patients to dialysis, medication, dietary and fluid restriction.
INTRODUCTION
Chronic Kidney Disease (CKD) affects individuals and health systems in low, middle and high income countries (1) and the global prevalence is estimated at 5 to 10%% (2) . CKD is also common in Africa although very limited data is collected on prevalence. Moreover, there are no reliable statistics about prevalence of CKD in all African countries due to lack of registries. The available data reveals consistent increase in the incidence of newly diagnosed individuals with CKD with a prevalence of about 10% (3, 4) .
CKD is deterioration in kidney function that results in kidney's inability to eliminate waste products, maintain acid base, fluid, and electrolyte balance (5) . The disease progression starts with acute kidney injury, which is rapid loss of renal function over hours to a few days, resulting from ischaemic or toxic injury to the kidney causing retention of nitrogenous wastes (6) . Untreated acute kidney injury will progress to CKD, an irreversible condition (7) with persistent decrease in estimated Glomerular Filtration Rate (GFR) for at least 3 months (8) and continuous albuminuria which increases gradually from mild to severe levels (9) .
A c c o r d i n g t o K i d n e y D i s e a s e International Guidelines Organisation(KDIGO) CKD Work Group (9) , the progression is from normal glomerular filtration rate (GFR) of 2 >90ml/min/1.73m (stage 1) to mild impairment 2 (GFR 60-90ml/min/1.73m ) (stage 2), then m o d e r a t e i m p a i r m e n t ( G F R 2 30-59ml/min/1.73m ) (stage 3) leading to severe 2 impairment (GFR 15-29ml/min/1.73m ) (stage 4). Ultimately, it leads to CKD stage 5 (Morton & Fontaine, 2009) which is complete failure of the kidneys to function at a level that is necessary for day-to-day life and kidney function less than 15% of normal GFR (9) .
Integrated management of CKD puts emphasis on dialysis, medication, and dietary and fluid restriction. Individuals with CKD have comorbid conditions namely diabetes mellitus and hypertension which contributes to more than 36% and 24% of cases of ESRD respectively (4) as well as an increased risk of developing complications that affect all systems of the body. O t h e r c a u s e s o f C K D i n c l u d e s glomerulonephritis, interstial nephritis, congenital malformations, genetic disorders and obstructive uropathy (4) . Therefore, medication is needed to manage comorbid and other conditions associated with CKD conditions as this slows the progression of CKD to end-of-life stages (10) .
Similarly, nutritional therapy in CKD minimises uremic and anaemia symptoms, reduce the incidence of fluid, electrolyte and acid base imbalances, reduce patient's vulnerability to infections and limit catabolism (11) . Moreover, removal and control of excess fluid is the cornerstone of volume management in CKD patients (12) as this prevent fluid overload. More importantly, Renal Replacement Therapy (RRT) is essential for management of advanced CKD and encompasses Chronic Ambulatory Peritoneal Dialysis (CAPD), haemodialysis and renal transplant (13) . Chronic peritoneal dialysis and haemodialysis are dialytic therapies which remove toxins; solutes and fluid from blood through three principal mechanisms namely osmosis, diffusion and filtration (14) .
In this regard, patients' adherence to dialytic procedures, medications, dietary and fluid restrictions is paramount in proper management of CKD population. Yet, low adherence to dialysis, medication, diet and fluid control is evident in more than half of the patients treated for CKD (15) . Furthermore, patients with CKD need to cope with dependence in performing activities of daily living such as detrimental physical symptoms, limitations in dietary and fluid intake, changes in body image, work and a crippled economic status (16) . The end result of these challenges is a cause of changed normal routines hence prediction of their control over treatment is difficult (18) . Although the available literature still indicates problems of adherence among CKD population, little or no summative reviews that document and quantify adherence in four modalities namely dialysis, medication, fluid and dietary restriction exist. . Therefore, this systematic literature review aims to document and quantify the level of adherence to dialysis, fluid, diet and medication from the results of previous studies and to identify instruments and methods of measuring adherence among CKD adult population.
MATERIALS AND METHODS
A conclusive literature search was conducted to identify studies that quantify adult CKD patient's adherence to medication, diet, fluid intake and dialysis. The following data bases were used to find the research articles: Medline, PubMed, Ebsco Host, CINAHL, google scholar and grey literature. The key words used for the search were: adherence, Chronic Kidney Disease, dialysis, medication, dietary and fluid restriction. The inclusion criteria included all research articles from 1993 to 2016. Included also in the review were quantitative articles written in English that accurately indicate and quantify the rate of adherence to medication, diet, fluid intake and dialysis among adult CKD population.
Excluded in the review were qualitative articles, articles with pediatric adherence (<18), intervention studies and case studies. Duplicates were also excluded after critical review by two independent reviewers. Figure 1 shows a flow chart of the search strategy for identified articles.
RESULTS
Overall, there were forty three (43) articles identified from the comprehensive search on CKD adherence. Operational definition of adherence was highlighted. Instruments and methods of measuring adherence in CKD population were also revealed. Moreover, studies that quantify adherence rates to dialysis, medication, fluid and diet control were identified. Of the forty three articles, seven (7) were identified for dialysis adherence, nine (9) were for medication adherence, 14 articles were for fluid adherence and 13 articles were for dietary adherence. The results of the review are presented as follows:
Adherence
Cramer et al (17) defined adherence as following the recommendations made by the provider with respect to timing, dosage, and frequency of medication taking where the patient follows the prescribed interval and dose. The same author highlighted adherence as a measure implemented over a period of time in percentage form. Sabate (18) echoed the same sentiments and included person's behavior in taking medication, following a diet and making changes in lifestyle according with health professional recommendations. In this review, adherence was conceptualised as CKD patients' ability and behaviour to follow a dialysis plan, medication, diet and fluid restriction with respect to right timing, right dosage at prescribed intervals.
Methods for measuring adherence in CKD patients
The methods of measuring adherence to dialysis, medication, fluid and dietary restriction in CKD patients were identified. The identified methods of assessing adherence in CKD patients were: self-report, biological markers and Intradialytic Weight Gain (IDWG) ( Table 1 )
Instruments used in measuring adherence for CKD patients
The instruments used in measuring adherence among CKD patients that have been developed and tested for use. The identified instruments include dialysis, diet and fluid nonadherence questionnaire (DDFQ) (19) and End Stage Renal Disease Adherence Questionnaire (ESRD: AQ) (20) which measures treatment adherence behaviors in four dimensions namely dialysis attendance, medication use, fluid restriction and diet recommendation ( Table 2) . Table 3 displays seven (7) studies identified for dialysis adherence. Sample size ranged from 40 in Turkey to 6251 in USA. The percentage of patients who are non-adherent through skipping varies from 2.5% in Turkey to 19% in USA (21, 22, 23, 24, 25, and 26) and through shortening from 20.3% to 32% in USA (22, 23) . In a study from Africa, Zimbabwe showed non-adherence rate of 97.6% which was very high (27) . On the contrary, non-adherence is virtually nonexistent in Japan and Sweden (25) .
Dialysis adherence

Medication adherence
Nine (9) studies revealed for medication adherence are shown in Table 4 . Sample sizes ranged from 30 to 5478 and rates of medication non-adherence were measured using self-report. Non adherence to phosphate binders, antihypertensive, calcium supplements and v i t a m i n s r a n g e d f r o m 3 % t o 8 0 % , antihypertensive and phosphate binders from 21% to 73% and phosphate binders alone ranged from 17.4% to 24% (28, 29, 30, 31, 32, 33, 34, and 35) . Still, there are no documented adherence rates to medication in literature for African region Table 5 shows fourteen (14) studies identified for fluid adherence of adult CKD patients and their non-adherence rates. The sample size ranged from 21 in the United Kingdom to 6251 in the USA. Self-report and intradialytic weight gain were used to measure fluid adherence in CKD participants. Non adherence using inter-dialytic weight gain ranged from 9.7% in USA to 70% in UK (24, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44) . Through self-report, non-adherence to fluid intake ranged from 40.3% in China to 72% in Belgium (19, 45) . Studies and documentation on adherence rates to fluid intake in African region were limited
Fluid adherence
Dietary adherence
There are thirteen studies selected for adult dietary adherence as shown in Table 6 . Sample size ranged from 62 in Hong Kong to 6251 in USA. In the case of potassium and phosphorus intake, dietary non-adherence is estimated at 2% in USA to nearly 39% in Hong Kong (18, 22, 24, 32, 35, 42) . Self-reported estimates of potassium and phosphorus intake ranged from 44% in Hong Kong to 81% in Belgium (19, 32, 46, 47) . Protein non-adherence ranged from 4.5% in Iran to 77% in USA. In South Africa, self-reported non adherence to renal diet was 84% (36) . Still, few documented published research studies on adherence rates in the African continent were found.
DISCUSSION
Methods of measuring adherence
Direct questioning and self-report instruments are most effective measures (19) if they are validated. The disadvantage of selfreport is bias as patients usually underestimate their non-adherence rates (48) . Biochemical markers are also important in measuring adherence in CKD patients. However, they are influenced by many other variables such as residual urine volume, dialysis sessions and body weight. Nonetheless, the continual lack of accepted value for each biochemical marker gives doubt to reliability of the tools that assesses rates adherence in CKD population (35) . For instance, potassium and phosphate values reflect residual renal function, dialysis adequacy and adherence with medication (35, 49) in addition to food intake (50, 51) .
Studies have shown that Intradialytic Weight Gain (IDWG) is a valid and objective measure of fluid restriction assessment in patients with CKD (24, 49, 52,) thus being widely used as an outcome measure (50, 52) in assessment of fluid restriction. Mean IDWG expressed as percent dry weight is one of the methods to measure fluid adherence (38) . However, it is seen as an unfit measure since dry weight can only be estimated. Nevertheless, the researchers continue to agree that IDWG should be defined as a percentage of dry weight (38, 53) . Furthermore, the point which defines fluid adherence is different in literature (54) . However, research based practice states that IDWG should be less than 2.5 kg or 3.5% of dry body weight so as to reduce the excess fluid during dialysis sessions (53) .
The disadvantage of biological markers is that they are influenced by many other variables such as residual urine volume, duration of dialysis session, the length of the intervals between 2 sessions and body weight. Nonetheless, lack of universally accepted cut off value for each marker raises the question of whether these measures are reliable tools to assess non adherence rates in CKD population (35) . Potassium and phosphate values reflect not only food intake (49, 50) but residual renal function, dialysis adequate, time at which blood was taken for analysis between dialysis, acid base and hormonal status and adherence with medication (32, 35)
Instruments for measuring adherence
There are differences in non-adherence rates due to lack of reliable instruments. Nevertheless, literature reveals two adherence scales that have been tested for use in patients with CKD. The dialysis, diet and fluid adherence instrument measures adherence to dialysis, fluid intake and dietary restrictions for the past two weeks (19) . However, the weakness of DDFQ lies in not addressing medication use among CKD patients.
Therefore measurement of adherence was limited. In view of this, Kim et al (20) , developed an End Stage Renal Disease Adherence Questionnaire (ESRD: AQ) which measures adherence behaviors in four modalities namely; dialysis, medication, fluid restriction and dietary intake. Therefore, this instrument maybe used to measure adherence in all the four d i m e n s i o n s w h i c h e n c o m p a s s e s t h e comprehensive care of patients with CKD.
Adherence to medication, fluid, dialysis and diet in CKD patients
Different rates of adherence are reported globally ( Table 7 ). The non-adherence rates to dialytic procedures, medication, fluid and dietary changes ranges from 0-53%, 1.2-81%, 3.4-74% and 1.2-82.4% respectively (21, 24, 28, 32, 35, 36, 37, 38) . This support documented evidence of poor adherence in all key aspects of integrated management among CKD patients. Dialysis has transformed the prognosis of patients with kidney disease but its effectiveness is unfortunately compromised by non-adherence (18) . Because of the demands of haemodialysis, many patients do not adhere to the prescribed regimen there by jeopardising successful clinical outcomes.
Inadequate adherence is common in CKD patients undergoing chronic haemodialysis and as many as 86% of the patients in the United Kingdom may be considered non-adherent to the treatment (17) .
The availability of data that reveals adherence rates to haemodialysis of renal failure patients is lacking in all African countries. The study done by Chironda et al (27) showed nonadherence to haemodialysis of 97.6%. This high rate of non-adherence in African countries is exacerbated by low socioeconomic status as most patients have no access to haemodialysis procedures and health insurance making care for CKD unaffordable (36) . World Kidney Day (2012) echoed the same sentiments of CKD patients discontinuing dialysis due to limited economic resources in developing nations Similarly, non-adherence to Peritoneal Dialysis (PD) dialysis procedure is scarce in literature although the dialytic procedure is available in all continents. Dean and Cruz (55) expressed the same sentiments and explained peritoneal dialysis as an inexpensive procedure which requires less infrastructure. Again, peritoneal dialysis is a convenient procedure which a patient can implement in their own homes. However, Lim et al (56) highlighted diminished and impairment of quality of life among patients on peritoneal dialysis. Griva et al (21) reveals the rates of non-adherence to Continuous Ambulatory Peritoneal Dialysis (CAPD) procedures ranged from 2.6-53%. The same author highlighted that missed PD exchanges were reported to be in a range of 2.5-53%, shortening by 4-15% of patients and performing less than 90% of prescribed exchanges was evident in 2-40% of patients. Indirect biochemical/ physiological measures reveals adherence rates at 74-78%.
Medication non-adherence remains a major obstacle among patients with CKD. Individuals with CKD have comorbid conditions as well as an increased risk of developing complications that affect all systems of the body, are more likely to die from these complications than CKD. Diuretics, antihypertensive and antidiabetics are of importance and these drugs have proved to slow progression of CKD (11) . Moreover, medications to manage pulmonary, gastrointestinal, neuromuscular, haematological, skeletal, integumentary and dietary intake alterations are needed (11) . These medications can only work effectively if CKD patients are fully adherent with their treatment.
Prevention of fluid overload is the basis for fluid management in patients with CKD. Available literature indicates a daily fluid allowance of 0.5 litres in addition to the volume equal to daily urine output (12) . Dietary sodium intake and medication containing sodium increase fluid overload (52) in patients with CKD. However, adequate dialysis removes excess fluid(57) in CKD patients. Therefore, effective fluid management in CKD population centres on dialysis, medication and dietary adherence.
Chronic Kidney failure needs dietary management in energy intake and nutrients to decrease morbidity and mortality (58) . CKD patients should avoid high sodium and potassium diet to manage hypertension thereby decreasing the incidence of stroke. Furthermore, diet low in saturated fats is advised as evidence highlight this group of patients as high risk for development of coronary artery disease due to elevated levels of serum triglycerides and low high density lipoproteins (59) .
CONCLUSION
Low adherence is of concern in CKD patients as previous studies reveal a greater number of patients deviating from dialysis, medication, fluid and dietary restrictions. There is need for more research and documentation of adherence rates among CKD patients especially in African countries. Controlling and managing the detrimental effects of CKD is the main focus. Therefore, the nephrology team which includes nephrologist, nurses, dieticians, social workers, dialysis technicians and pharmacists should implement a multidisciplinary approach in engaging CKD patients with their management. This will promote positive adherent behaviors and consequently effective management of the CKD population. Adherence in CKD patient Geldine et al.
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